Advertisement
Screener

MARINUS PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

MARINUS PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities, Continuing Operations

MARINUS PHARMACEUTICALS, INC. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $1.64 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-01.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-05-01

  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $1.64M.
  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was -$917.00K, a 103.25% decline year-over-year.
  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was -$1.00M.
  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-06-30 was -$152.00K, a 547.06% decline year-over-year.
  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was -$2.17M, a 107.63% decline from fiscal 2015.
  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $28.45M, a 41.11% decline from fiscal 2014.
  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $48.30M, a 500.21% increase from fiscal 2013.
  • MARINUS PHARMACEUTICALS, INC. net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $8.05M.
Period endNet Cash Provided by (Used in) Financing Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month as first filedNet Cash Provided by (Used in) Financing Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month as first filedNet Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month
2017-03-31$1.64M
10-Q · filed 2017-05-01
$718.00K
derived: sum of 2 quarters · filed 2017-05-01
-$283.00K
derived: sum of 3 quarters · filed 2017-05-01
-$435.00K
derived: sum of 4 quarters · filed 2017-05-01
2016-12-31-$917.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
-$1.92M
derived: sum of 2 quarters · filed 2017-03-13
-$2.07M
derived: sum of 3 quarters · filed 2017-03-13
-$2.17M
10-K · filed 2017-03-13
2016-09-30-$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
-$1.15M
derived: sum of 2 quarters · filed 2016-11-08
-$1.25M
10-Q · filed 2016-11-08
$26.99M
derived: sum of 4 quarters · filed 2017-05-01
2016-06-30-$152.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$253.00K
10-Q · filed 2016-08-09
$27.99M
derived: sum of 3 quarters · filed 2017-05-01
$27.96M
derived: sum of 4 quarters · filed 2017-05-01
2016-03-31-$101.00K
10-Q · filed 2017-05-01
$28.14M
derived: sum of 2 quarters · filed 2017-05-01
$28.11M
derived: sum of 3 quarters · filed 2017-05-01
$28.14M
derived: sum of 4 quarters · filed 2017-05-01
2015-12-31$28.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$28.21M
derived: sum of 2 quarters · filed 2017-03-13
$28.25M
derived: sum of 3 quarters · filed 2017-03-13
$28.45M
10-K · filed 2017-03-13
2015-09-30-$32.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$2.00K
derived: sum of 2 quarters · filed 2016-11-08
$202.00K
10-Q · filed 2016-11-08
$4.82M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$34.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$234.00K
10-Q · filed 2016-08-09
$4.85M
derived: sum of 3 quarters · filed 2017-03-13
$46.65M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$200.00K
10-Q · filed 2016-05-02
$4.82M
derived: sum of 2 quarters · filed 2017-03-13
$46.61M
derived: sum of 3 quarters · filed 2017-03-13
$48.59M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$4.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$46.41M
derived: sum of 2 quarters · filed 2017-03-13
$48.39M
derived: sum of 3 quarters · filed 2017-03-13
$48.30M
10-K · filed 2017-03-13
2014-09-30$41.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29
$43.77M
derived: sum of 2 quarters · filed 2015-10-29
$43.69M
10-Q · filed 2015-10-29
$43.69M
10-Q · filed 2014-11-13
$44.19M
derived: sum of 4 quarters · filed 2015-10-29
2014-06-30$1.98M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04
$1.89M
10-Q · filed 2015-08-04
$1.89M
10-Q · filed 2014-10-10
$2.39M
derived: sum of 3 quarters · filed 2015-08-04
$2.39M
derived: sum of 4 quarters · filed 2015-08-04
2014-03-31-$82.00K
10-Q · filed 2015-05-14
$419.72K
derived: sum of 2 quarters · filed 2015-05-14
$419.72K
derived: sum of 3 quarters · filed 2015-05-14
2013-12-31$501.72K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$501.72K
derived: sum of 2 quarters · filed 2015-03-12
$8.05M
10-K · filed 2015-03-12
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$7.55M
10-Q · filed 2014-11-13
2013-06-30$7.55M
10-Q · filed 2014-10-10